About
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. It serves healthcare professionals, travelers, investors, partners, and the general public from operations in Austria, Sweden, the United Kingdom, France, Canada, and the United States.
Services
Vaccine development
Develops prophylactic vaccines for infectious diseases with major unmet needs, including candidates in vector-borne, bacterial, and viral disease areas.
Vaccine manufacturing
Manufactures clinical and commercial products through its global in-house manufacturing network and GMP facilities.
CDMO: development & manufacturing
Commercialization of vaccines
Commercializes three vaccines in its travel health portfolio.
Marketing and distribution
Provides specialist commercial capability for distribution of travelers’ vaccines in key travel vaccine markets.
Technical development
Provides process and assay development for viral and bacterial vaccines.
Clinical immunology assay development and sample testing
Offers clinical immunology assay development and sample testing services.
Clinical manufacturing
Provides clinical manufacturing services.
CDMO: development & manufacturing
In vivo testing
Provides in vivo testing for preclinical proof of concept, immunogenicity, and safety assessments.
3 more services
- Clinical strategy and operations
- Manufacturing and services for third parties
- Travel health support
Capabilities
- Assays and studies
- Immunogenicity
- In vivo
- Process development
- Assay development
- Clinical immunology assay development
- Sample testing
3 more
- In vivo testing
- Clinical immunology assays
- Process development assays
- Scale and capacity
- Three in-house operations
- Three own operating sites
- >650 employees in six countries
- Therapeutic areas
- Infectious diseases
- Travel health
- Vector-borne diseases
- Bacterial vaccines
- Viral vaccines
- Lyme disease
5 more
- Chikungunya
- Shigellosis
- Cholera
- Japanese encephalitis
- Shigella
Modalities and species
- Modalities
- ADC
- Recombinant protein
- Vaccine
- Species and models
- Borrelia
- Ixodes ticks
- Aedes mosquitoes
- Shigella bacteria
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: GMP (production and release of commercial and clinical trial products)
Industries served
- Vaccines
- Travel health
Company
- Founded
- 1999
- Size
- 501-1000 employees
- Ownership
- Small business, as registered with SAM.gov or stated on their site
Locations
- Office
- 3535 Saint-Charles Blvd., Suite 600 Kirkland, Québec H9H 5B9 Canada
- Sites
- Vienna, Austria · Livingston, Scotland · Solna, Sweden · Montreal, Canada · Bethesda, United States · Fleet, United Kingdom
- Serves
- Europe, North America, key travel vaccine markets, low- and middle-income countries, worldwide
Contacts
- Phone
- +33 4 78 76 61 01